Yazar "Çakmak, Hüseyin Altuğ" için listeleme
-
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)
Ekici, Berkay; Yaman, Mehmet; Küçük, Murathan; Dereli, Seçkin; Yenerçağ, Mustafa; Yiğit, Zerrin; Baş, Mehmet Memduh; Karavelioğlu, Yusuf; Çakmak, Hüseyin Altuğ; Kıvrak, Tarık; Özkan, Hakan; Altın, Cihan; Şabanoğlu, Cengiz; Demirkan, Burcu; Ataş, Ali Ekber; Kılıçaslan, Fethi; Altay, Hakan; Tengiz, İstemihan; Erkan, Aycan Fahri; Kılıçaslan, Barış; Olgun, Fatih Erkam; Durakoğlugil, Murtaza Emre; Alhan, Aslıhan; Zoghi, Mehdi (Turkish Society of Cardiology, 2021)Objective: Heart failure (HF) is a growing public health problem with high morbidity and mortality. Recently, angiotensin receptor neprilysin inhibitor (ARNi) has emerged as a promising treatment for HF with reduced ejection ... -
Long-term prognosis of patients with heart failure: Follow-up results of journey HF-TR study population
Şabanoğlu, Cengiz; Sinan, Ümit Yaşar; Akboğa, Mehmet Kadri; Çoner, Ali; Gök, Gülay; Kocabaş, Umut; Bekar, Lütfü; Gazi, Emine; Cengiz, Mahir; Kılıç, Salih; İnanç, İbrahim Halil; Çakmak, Hüseyin Altuğ (Turkish Society of Cardiology, 2023)Background: Despite advances in therapeutic management of patients with heart failure, there is still an increasing morbidity and mortality all over the world. In this study, we aimed to present the 3-year follow-up outcomes ... -
Slow ad hoc percutaneous coronary intervention strategy and coronary diameters
Olcay, Ayhan; Çakmak, Hüseyin Altuğ; Bigmurad, T. O.; Eren, Fatime; Keskin, Kudret; Yıldız, Ahmet; Cantürk, Emir; Kayhan, Bekir (Elsevier, 2013)Introduction: In the era of coronary stenting, ad hoc percutaneous coronary intervention (PCI) can be performed in most of the patients with stable or unstable coronary artery disease as safely and successfully. In elective ...